What do systematic reviews say?

Culturally adapted health literacy skills building course vs no/unrelated health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 229 participants
  Low

Culturally adapted health literacy skills building course vs no/unrelated health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 111 participants
  Low

Culturally adapted health literacy skills building course vs no/unrelated health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 229 participants
  Low

Culturally and literacy adapted audio‐/visual education without personal feedback vs no health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 293 participants
  Low

Culturally and literacy adapted audio‐/visual education without personal feedback vs written information on the same topic

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 240 participants
  Moderate

Culturally and literacy adapted audio‐/visual education without personal feedback vs written information on the same topic

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 987 participants
  Low

Culturally and literacy adapted audio‐/visual education without personal feedback vs written information on the same topic

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 240 participants
  Low

Culturally and literacy adapted self‐management programme vs no health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 514 participants
  Low

Female migrants' benefit of any health literacy intervention vs male migrants' benefit of any health literacy intervention

• Interventions for improving health literacy in migrants 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 77 participants
  Very low

Exercise vs no exercise

• Exercise interventions for adults with cancer receiving radiation therapy alone 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 112 participants
  Low

Exercise vs no exercise

• Exercise interventions for adults with cancer receiving radiation therapy alone 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 112 participants
  Low

Exercise vs no exercise

• Exercise interventions for adults with cancer receiving radiation therapy alone 2023 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 112 participants
  Very low

Exercise vs no exercise

• Exercise interventions for adults with cancer receiving radiation therapy alone 2023 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 58 participants
  Very low

Prebiotic vs another prebiotic

• Synbiotics, prebiotics and probiotics for people with chronic kidney disease 2023 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 24 participants
  GRADE not reported

Summary of findings table ‐ Oral classical immunosuppressants (prednisolone or cyclosporine) vs placebo

It is very uncertain whether summary of findings table ‐ Oral classical immunosuppressants… changes short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (very low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 4.68 [0.57, 38.27]
  2 studies · 79 participants
  Very low

Summary of findings table ‐ Subcutaneous biologics (dupilumab) vs placebo

Summary of findings table ‐ Subcutaneous biologics (dupilumab) showed no clear difference in short‐term hair regrowth ≥ 75% compared with placebo (low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 3.59 [0.19, 66.22]
  1 study · 60 participants
  Low

Summary of findings table ‐ Oral small molecule inhibitors (apremilast or baricitinib) vs placebo

Summary of findings table ‐ Oral small molecule inhibitors… leads to higher short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (high certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 7.54 [3.9, 14.58]
  2 studies · 1200 participants
  High

Summary of findings table ‐ Oral small molecule inhibitors (ruxolitinib) vs oral small molecule inhibitors (tofacitinib)

It is very uncertain whether summary of findings table ‐ Oral small molecule inhibitors… changes short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with oral small molecule inhibitors (tofacitinib) (very low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 1.08 [0.77, 1.52]
  1 study · 80 participants
  Very low

Summary of findings table ‐ Topical small molecule inhibitors (ruxolitinib) vs placebo

Summary of findings table ‐ Topical small molecule inhibitors… showed no clear difference in short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 5 [0.25, 100.89]
  1 study · 78 participants
  Low

Summary of findings table ‐ Contact immunotherapy (diphencyprone or squaric acid dibutil ester) vs placebo

It is very uncertain whether summary of findings table ‐ Contact immunotherapy (diphencyprone or… changes short‐term hair regrowth ≥ 75% (between 12 and 26 weeks of compared with placebo (very low certainty).

• Treatments for alopecia areata: a network meta‐analysis 2023 · Cochrane Headline outcomes only
  RR 1.16 [0.79, 1.71]
  1 study · 99 participants
  Very low